AGN-241751

DRUG2 trials

Sponsors

Syndeio Biosciences, Inc

Conditions

Depressive Disorder, MajorMajor Depressive Disorder

Phase 1

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

CompletedNCT03726658

Syndeio Biosciences, IncMajor Depressive Disorder

Start: 2018-11-08End: 2019-10-23Updated: 2026-04-07

Phase 2

Zelquistinel in the Treatment of Major Depressive Disorder

CompletedNCT03586427

Syndeio Biosciences, IncDepressive Disorder, Major

Start: 2018-06-13End: 2019-08-21Updated: 2026-04-27